SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form 424B4 - Prospectus [Rule 424(b)(4)]:
SEC Accession No. 0001493152-21-021374
Filing Date
2021-08-27
Accepted
2021-08-27 06:06:32
Documents
24

Document Format Files

Seq Description Document Type Size
1 form424b4.htm 424B4 2524620
2 logo_001.jpg GRAPHIC 7906
3 image_002.jpg GRAPHIC 144198
4 figure02_01.jpg GRAPHIC 268196
5 figure03_01.jpg GRAPHIC 325033
6 figure04_01.jpg GRAPHIC 176854
7 image_003.jpg GRAPHIC 194757
8 figure07_01.jpg GRAPHIC 189782
9 figure05_01.jpg GRAPHIC 190604
10 figure08_01.jpg GRAPHIC 120168
11 image_004.jpg GRAPHIC 180739
12 image_005.jpg GRAPHIC 63267
13 figure11_01.jpg GRAPHIC 174005
14 image_006.jpg GRAPHIC 262529
15 figure13_01.jpg GRAPHIC 103898
16 figure14_01.jpg GRAPHIC 102828
17 figure15_01.jpg GRAPHIC 96511
18 figure16_01.jpg GRAPHIC 83018
19 figure17_01.jpg GRAPHIC 82111
20 figure18_01.jpg GRAPHIC 106743
21 figure19_01.jpg GRAPHIC 89753
22 figure20_01.jpg GRAPHIC 97710
23 figure21_01.jpg GRAPHIC 90793
24 figure22_01.jpg GRAPHIC 120336
  Complete submission text file 0001493152-21-021374.txt   7033231
Mailing Address 333 W. SANTA CLARA STREET, SUITE 900 SAN JOSE CA 95110
Business Address 333 W. SANTA CLARA STREET, SUITE 900 SAN JOSE CA 95110 408-800-2649
RenovoRx, Inc. (Filer) CIK: 0001574094 (see all company filings)

IRS No.: 271448452 | State of Incorp.: DE | Fiscal Year End: 1231
Type: 424B4 | Act: 33 | File No.: 333-258071 | Film No.: 211214040
SIC: 2834 Pharmaceutical Preparations